Relevant WHO guidance for SARS-COV2 COVID-19 treatment - Medicines

Overview

This document is intended to highlight some of the most relevant World Health Organization (WHO) guidance in the area of pharmaceutical quality assurance and regulatory guidelines for medicines adopted by the WHO Expert Committee on Specificationsfor Pharmaceutical Preparationsand published in WHO’s Technical Report Series (TRS)1 , that may support the development, production, evaluation, distribution and quality control of medicines intended forCOVID-19treatment. This list is prepared following the different product/life-cyclephases and tools provided by WHO.